Bogusz Patricia 4
4 · BioScrip, Inc. · Filed May 17, 2012
Insider Transaction Report
Form 4
BioScrip, Inc.BIOS
Bogusz Patricia
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock, Par Value $0.0001 Per Share
2012-05-14$6.49/sh+5,000$32,450→ 8,028 total - Exercise/Conversion
Common Stock, Par Value $0.0001 Per Share
2012-05-14$2.47/sh+9,000$22,230→ 17,028 total - Sale
Common Stock, Par Value $0.0001 Per Share
2012-05-14$7.52/sh−14,000$105,280→ 3,028 total - Exercise/Conversion
Employee Stock Option
2012-05-14−5,000→ 0 totalExercise: $6.49From: 2006-10-24Exp: 2015-10-24→ Common Stock, $.0001 Par Value (5,000 underlying) - Exercise/Conversion
Employee Stock Option
2012-05-14−9,000→ 0 totalExercise: $2.47From: 2007-11-01Exp: 2016-11-01→ Common Stock, $.0001 Par Value (9,000 underlying)
Holdings
- 7,875
Common Stock, $.0001 Par Value
- 19,687
Employee Stock Option
Exercise: $6.52From: 2009-04-29Exp: 2018-04-29→ Common Stock, $.0001 Par Value (19,687 underlying) - 20,000
Employee Stock Option
Exercise: $2.73From: 2010-04-28Exp: 2019-04-28→ Common Stock, $.0001 Par Value (20,000 underlying) - 10,000
Employee Stock Option
Exercise: $6.46From: 2011-07-27Exp: 2020-07-27→ Common Stock, $.0001 Par Value (10,000 underlying) - 20,000
Employee Stock Option
Exercise: $4.24From: 2012-03-01Exp: 2021-03-01→ Common Stock, $.0001 Par Value (20,000 underlying) - 50,000
Employee Stock Option
Exercise: $4.42From: 2012-04-26Exp: 2021-04-26→ Common Stock, $.0001 Par Value (50,000 underlying) - 100,000
Employee Stock Option
Exercise: $6.62From: 2013-03-08Exp: 2022-03-08→ Common Stock, $.0001 Par Value (100,000 underlying)
Footnotes (3)
- [F1]Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.51 to $7.59 inclusive. The reporting person undertakes to provide to BioScrip, Inc., any security holder of BioScrip, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges forth in this footnote.
- [F3]Unvested